regeneron glp-1 gip treatment muscle loss side effects Triple Agonism Based Therapies for Obesity | Current Cardiovascular Risk Reports Targeting GLP-1, GIP & GCG

GLP-1 drugs such as Ozempic, Wegovy, and Mounjaro were initially developed to treat type 2 diabetes, but their effectiveness as anti-obesity medications has generated tremendous excitement and high demand among people who have struggled to lose weight by other means

Hemi et al

What has become increasingly clear is that GLP-1 receptors are expressed throughout the bodyin the brain, heart, endothelium, pancreas, and immune cellsmaking this pathway a powerful modulator of systemic aging processes

Disclosure timing: Medication type and pharmacy routing are resolved after clinician review

Wilding JP, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al

Instead, any shifts in lab values are usually indirect: TSH (Thyroid Stimulating Hormone): In large-scale datasets like the Epic Cosmos study, researchers observed that some patients see a slight decrease in TSH levels